Gufic Biosciences Limited (GUFICBIO.NS) NSE
361.75
+12.6(+3.61%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
361.75
+12.6(+3.61%)
Currency In INR
| Market Cap | 27.47B |
| Enterprise Value | 30.76B |
| P/E Ratio | 56.56 |
| PEG Ratio | -7.15 |
| Price/Sales Ratio | 3.84 |
| Price/Book Ratio | 5.46 |
| Enterprise/Revenue | 4.19 |
| Enterprise/EBITDA | 25.62 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.07 |
| Operating Margin | 0.13 |
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
| Revenue | 9.44B |
| Revenue/Share | 93.99 |
| Gross Profit | 3.4B |
| EBITDA | 1.51B |
| Net Income | 642.15M |
| Diluted EPS | 6.4 |
| Total Cash | 762.17M |
| Total Cash/Share | 7.59 |
| Total Debt | 4.05B |
| Total Debt/Equity | 0.61 |
| Current Ratio | 1.55 |
| Book Value Per Share | 66.21 |
| 52-Week Change | -1.19 |
| 52-Week High | 407.85 |
| 52-Week Low | 268 |
| Moving Average 50 Days | 296.62 |
| Moving Average 200 Days | 323.91 |
| Average Volume | 80,843 |
| Shares Outstanding | 100.28M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 0.03 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |